top of page

SAMHSA Releases Advisory on Prescription Stimulant Misuse Among Youth and Young Adults

SAMHSA has released a new advisory regarding prescription stimulant misuse among youth and young adults. As described by SAMHSA, the advisory reviews the evidence on prescription stimulant misuse, discusses the health effects and risk factors for misuse among youth and young adults, establishes prescription stimulant misuse as a public health problem, identifies associated risk and protective factors, opportunities for prevention and treatment, and provides programs and action steps for practitioners, educators, and parents to prevent misuse.

3 views0 comments

Recent Posts

See All

SAMHSA [3/27] | In a letter to clinicians, SAMHSA wrote that xylazine is an emerging public health threat and noted that routine toxicology tests do not test for the substance. Cont.

bottom of page